Serum Testosterone Levels Are Related to Cognitive Function in Men with Schizophrenia
Overview
Neurology
Psychiatry
Authors
Affiliations
Background: Sex steroids such as oestrogen and testosterone are potent neurodevelopmental hormones that also play a role in neuromodulation and neuroprotection of the mature brain. Sex steroid hormones may also be involved in the pathophysiology of schizophrenia as reduced circulating sex steroid levels and changes in brain sex steroid receptors are found in people with schizophrenia compared to controls. In men with schizophrenia, recent studies have documented an inverse correlation between serum testosterone and negative symptoms. Our study sought to confirm whether men with schizophrenia had lower levels of testosterone relative to controls and to determine whether lower testosterone levels were related to higher symptom severity and impaired cognition.
Method: Circulating serum hormone levels (testosterone, oestrogen, and prolactin), cognitive function and symptoms were assessed in 29 chronically ill men with schizophrenia or schizoaffective disorder. Twenty healthy men were recruited as a comparison group. A series of regression analyses were performed to determine the extent to which circulating sex steroid hormone levels predict cognition and symptoms in men with schizophrenia.
Results: We did not find a significant difference in serum testosterone levels between groups. However, circulating testosterone levels significantly predicted performance on verbal memory, processing speed, and working memory in men with schizophrenia. With the exception of an effect of oestrogen on verbal memory, circulating sex steroid levels did not predict cognitive function in healthy men. Testosterone levels were not related to positive or negative symptom severity, but testosterone influenced excitement/hostility levels in our schizophrenia sample.
Conclusions: The results suggest that circulating sex steroids may modulate cognitive deficits associated with schizophrenia.
Brand B, de Boer J, Willemse E, Weickert C, Sommer I, Weickert T Arch Womens Ment Health. 2024; 27(6):931-941.
PMID: 38995314 PMC: 11579114. DOI: 10.1007/s00737-024-01491-9.
Luo G, Bai F, Qu X, Jing Y, Wang S, Xuekelaiti Z J Neural Transm (Vienna). 2024; 131(4):385-391.
PMID: 38277043 DOI: 10.1007/s00702-024-02748-4.
Wu F, Yi Y, Lian Y, Chen Q, Luo L, Yang H Eur Arch Psychiatry Clin Neurosci. 2023; 274(6):1355-1363.
PMID: 37184751 DOI: 10.1007/s00406-023-01616-8.
The Hypothalamic-Pituitary-Gonadal Axis in Men with Schizophrenia.
Matuszewska A, Kowalski K, Jawien P, Tomkalski T, Gawel-Dabrowska D, Merwid-Lad A Int J Mol Sci. 2023; 24(7).
PMID: 37047464 PMC: 10094807. DOI: 10.3390/ijms24076492.
Altered Connectivity of the Frontoparietal Network During Attention Processing in Prolactinomas.
Cao C, Wang Y, Liu J, Chen A, Lu J, Xu G Front Neurol. 2021; 12:638851.
PMID: 34526949 PMC: 8435841. DOI: 10.3389/fneur.2021.638851.